Figure 7.
Figure 7. Fas/FasL and MHC class I are not required for Tr1-induced cytotoxicity. (A) FACS analysis for expression of FasL on CD4+ and CD8+ effector T lymphocytes. Methods of stimulation (over 4 days) are shown. (B) A FasL blocking antibody (clone DX2; 10 μg/200 μL) does not block the cytotoxicity of Tr1 regulatory cells against target cells (U937 and K562) at 4 and 8 hours. E/T ratios and EGTA controls for perforin-dependent cytotoxicity are shown. Data are representative of more than 3 independent experiments showing similar results. Values shown are the mean ± SD; *P < .05; **P < .01; ***P < .001. (C) FACS analysis for Fas, MHC class II (DR), and MHC class I (A, B, C) on U937 and K562 cells. Percentage of total cells in each quadrant is shown in the upper right corner of each subpanel in panels A and C.

Fas/FasL and MHC class I are not required for Tr1-induced cytotoxicity. (A) FACS analysis for expression of FasL on CD4+ and CD8+ effector T lymphocytes. Methods of stimulation (over 4 days) are shown. (B) A FasL blocking antibody (clone DX2; 10 μg/200 μL) does not block the cytotoxicity of Tr1 regulatory cells against target cells (U937 and K562) at 4 and 8 hours. E/T ratios and EGTA controls for perforin-dependent cytotoxicity are shown. Data are representative of more than 3 independent experiments showing similar results. Values shown are the mean ± SD; *P < .05; **P < .01; ***P < .001. (C) FACS analysis for Fas, MHC class II (DR), and MHC class I (A, B, C) on U937 and K562 cells. Percentage of total cells in each quadrant is shown in the upper right corner of each subpanel in panels A and C.

Close Modal

or Create an Account

Close Modal
Close Modal